Multi-Model Clinical Review

CASE CONTEXT Case ID: 1 Patient: Eddy Species: Canine Breed: Border Collie Sex: Male Weight kg: 23.00 BCS: 7.00 CASE DETAILS Primary Complaint: Vomiting for 2 days Case Status: Open Initial Differential Notes: Suspect FB vs Garbage vs Bacterial infection IMAGING SNAPSHOT EVIDENCE [06/06/2026] X-ray - Chest Affected Systems: Gastrointestinal, Hepatic, Renal, Musculoskeletal, Pulmonary Physical Evidence: Abnormal gastric contents; hepatomegaly with characteristic radiographic signs; renomegaly with mineralization; thoracolumbar disc space narrowing; spondylosis; cranioventral lung opacity with interstitial/alveolar pattern. DAMNIT-V Mapping: { "D": "Degenerative spinal disease (spondylosis, disc space narrowing)", "A": "None noted", "M": "Metabolic/endocrine liver disease (hepatic lipidosis, endocrinopathy)", "N": "Possible neoplasia (hepatic, renal, pulmonary)", "I": "Inflammatory/infectious (pneumonia, hepatitis, pneumonitis)", "T": "Traumatic pulmonary hemorrhage/contusion differential", "V": "Vascular venous congestion in hepatomegaly" } Conventional Flags: Hepatomegaly, renomegaly with mineralization, thoracolumbar disc space narrowing, spondylosis, cranioventral pulmonary opacity, abnormal gastric material. Snapshot Evidence: Radiographs show abnormal gastric contents, enlarged liver and kidneys with mineralization, degenerative spinal changes including disc space narrowing and spondylosis, and increased opacity in cranioventral lung lobes consistent with pneumonia or other pulmonary pathology. These findings suggest multi-system involvement requiring further clinical correlation and diagnostics. PATHOLOGY / LABORATORY SNAPSHOT EVIDENCE [06/06/2026] Biochemistry - Pre GA Laboratory: Idexx Affected Systems: - Hematologic system: low MCHC, high platelet count and plateletcrit. - Renal system: elevated creatinine and urea. - Hepatic system: elevated ALT. - No significant abnormalities in white blood cell counts or differential. Physical Evidence: - MCHC (Mean Corpuscular Hemoglobin Concentration): 30.9 g/dL (Low; RI 32.0 - 37.9) - Platelets (PLT): 679 K/µL (High; RI 148 - 484) - PCT (Plateletcrit): 0.71 % (High; RI 0.14 - 0.46) - Creatinine (CREA): 230 µmol/L (High; RI 44 - 159) - Urea: 12.4 mmol/L (High; RI 2.5 - 9.6) - ALT (Alanine Aminotransferase): 221 U/L (High; RI 10 - 125) - SDMA: 9 µg/dL (Normal; RI 0 - 14) - Other CBC parameters (RBC, HCT, HGB, MCV, MCH, RDW, WBC, NEU, LYM, MONO, EOS, BASO) within normal limits. DAMNIT-V Mapping: - M (Metabolic / nutritional / endocrine / renal / hepatic / biochemical burden): Elevated CREA and UREA indicate renal involvement; elevated ALT indicates hepatic involvement. - I (Inflammatory / infectious / immune-associated evidence): Elevated platelets and plateletcrit may indicate inflammation or reactive thrombocytosis. - N (Neoplastic / proliferative): No direct evidence. - D (Degenerative / chronic structural): Possible chronic renal changes suggested by CREA and UREA elevation. - T, V, A: No direct evidence. Conventional Flags: - Low MCHC: may indicate hypochromia, possibly related to iron deficiency or chronic disease. - High platelets and PCT: reactive thrombocytosis or inflammation. - High creatinine and urea: azotemia, possible renal dysfunction. - High ALT: hepatocellular injury or leakage. - Normal SDMA: suggests early or mild renal impairment or non-renal causes of creatinine elevation. Snapshot Evidence: - Hematology: Mild hypochromia (low MCHC), thrombocytosis. - Biochemistry: Azotemia (high CREA and UREA), elevated liver enzyme (ALT). - No leukocytosis or left shift to suggest acute infection. - SDMA normal, suggesting renal function may be stable or early dysfunction. - Platelet parameters elevated, possibly indicating inflammatory or reactive process. This evidence supports renal and hepatic system involvement with possible inflammatory component; hematologic changes are mild and may be secondary. Further renal function tests and urinalysis recommended for comprehensive assessment. CURRENT EVIDENCE COUNTS Imaging reports: 1 Pathology reports: 1 Other evidence layers are retained in their own modules and will be added to this evidence base in Snapshot V2.

Conventional Veterinary Model: - Likely Differentials: • Foreign body (FB) or garbage ingestion causing gastric irritation or obstruction • Infectious or inflammatory pneumonia (cranioventral lung opacity) • Hepatic disease (hepatomegaly, elevated ALT) possibly metabolic/endocrine or inflammatory hepatitis • Renal disease (renomegaly with mineralization, azotemia) possibly chronic kidney disease or nephritis • Degenerative spinal disease (spondylosis, disc space narrowing) contributing to chronic pain or systemic effects - Serious Rule-Outs: • Neoplasia involving liver, kidney, or lung (not ruled out by imaging) • Severe bacterial pneumonia or aspiration pneumonia requiring urgent treatment • Acute renal failure or progressive chronic kidney disease • Gastric obstruction or perforation secondary to foreign body - Missing Tests: • Abdominal ultrasound to assess liver, kidneys, and gastrointestinal tract in detail • Urinalysis including sediment exam and urine protein:creatinine ratio to evaluate renal function • Coagulation profile given thrombocytosis and possible inflammation • Thoracic ultrasound or CT to better characterize pulmonary opacity • Infectious disease titers or cultures if infection suspected • Repeat CBC to monitor platelet trends and anemia status - Monitoring Markers: • Renal parameters (creatinine, urea, SDMA) and urine output • Hepatic enzymes (ALT, AST, ALP) and bilirubin • Platelet counts and inflammatory markers (CRP if available) • Clinical signs: vomiting frequency, appetite, hydration, respiratory status Traditional Chinese Medicine Model: - Possible Patterns: • Spleen Qi deficiency with Damp accumulation suggested by vomiting and abnormal gastric contents • Liver Qi stagnation or Liver Blood deficiency possible due to hepatomegaly and elevated ALT • Kidney Yin deficiency or Kidney Qi weakness indicated by renomegaly and azotemia • Lung involvement with Damp-Heat or Phlegm accumulation consistent with cranioventral lung opacity and pneumonia pattern • Five Element themes: Earth (Spleen/Stomach) dysfunction affecting digestion; Water (Kidney) imbalance affecting renal system; Wood (Liver) involvement with hepatic signs - Food Energetics: • Avoid cold, greasy, or damp-producing foods that may exacerbate Spleen Qi deficiency and Damp • Consider warming, easily digestible foods to support Spleen and Stomach function • Support Kidney with foods that nourish Yin and Qi, such as bone broth or kidney-supportive herbs (to be evaluated by TCM practitioner) - Uncertainty remains regarding precise pattern dominance and channel involvement without pulse/tongue exam Homeopathic Model: - Remedy-Picture Themes: • Constitutional observations needed: modalities (better/worse with heat/cold, time of day), mental/emotional state, appetite changes, thirst, stool and urine characteristics • Vomiting with multi-system involvement may suggest remedies with gastrointestinal and systemic action (e.g., Nux vomica, Arsenicum album), but specifics lacking • Elevated platelets and inflammatory signs may indicate a remedy picture involving reactive or inflammatory states - Missing Characteristic Symptoms: • Modalities (aggravations and ameliorations) • Detailed mental/emotional symptoms • Specific nature and character of vomiting (e.g., projectile, bile-stained) • Sensory symptoms (pain type, location) • Sleep patterns and general constitution - No final remedy indicated without fuller symptom picture Anthroposophic Model: - System Interpretation: • Nerve-Sense System: Degenerative spinal changes (spondylosis, disc narrowing) suggest disturbance in nerve-sense system affecting structural integrity and sensory input • Rhythmic System: Pulmonary involvement (opacity) and hepatic enlargement may reflect imbalance in rhythmic system, which governs heart-lung and liver-spleen rhythms • Metabolic-Limb System: Renal enlargement and biochemical changes indicate metabolic-limb system stress, affecting excretion and metabolic regulation - Life Process Themes: • Liver involvement may reflect impaired transformation and detoxification processes • Kidney changes suggest disturbance in fluid regulation and metabolic waste elimination • Lung opacity may indicate impaired respiratory exchange and rhythmic system disruption - Organ-Process Themes: • Liver as metabolic center and blood regulator • Kidney as filter and fluid balance organ • Lung as respiratory and rhythmic system organ - Interpretation remains tentative without further clinical and functional data Cross-Model Agreement: - Agreement: • Liver involvement is consistently noted (Conventional: hepatomegaly, elevated ALT; TCM: Liver Qi/Blood; Anthroposophic: rhythmic system/liver process) • Kidney involvement is supported across models (Conventional: azotemia, renomegaly; TCM: Kidney Yin/Qi; Anthroposophic: metabolic-limb system) • Pulmonary involvement is recognized (Conventional: cranioventral opacity; TCM: Lung Damp-Heat/Phlegm; Anthroposophic: rhythmic system) - Divergence: • Degenerative spinal disease is emphasized in Conventional and Anthroposophic (nerve-sense system) but less so in TCM and Homeopathy at this stage • Homeopathic model requires more symptom detail to align with other models - Evidence Tensions: • Elevated creatinine with normal SDMA suggests early or mild renal impairment, creating some uncertainty about severity • Lack of leukocytosis despite pulmonary opacity may challenge infectious pneumonia diagnosis, raising differential for sterile inflammation or neoplasia Rule-In / Rule-Out Priorities: - Rule-In: • Hepatic involvement (rule-in by hepatomegaly, elevated ALT) • Renal involvement (rule-in by azotemia, renomegaly) • Pulmonary pathology (rule-in by cranioventral opacity) • Degenerative spinal disease (rule-in by imaging) - Rule-Out: • Acute bacterial infection (pending lack of leukocytosis but cannot be excluded) • Neoplasia (cannot be ruled out without further imaging/biopsy) • Gastric obstruction (rule-out pending abdominal ultrasound) - Evidence Pending: • Infectious vs inflammatory pulmonary process • Severity and reversibility of renal impairment • Presence of foreign body or gastric obstruction • Coagulation abnormalities or bleeding risk given platelet changes - Local Veterinary Not-to-Miss Cautions: • Monitor for signs of respiratory distress or worsening azotemia • Risk of gastric perforation or obstruction requiring urgent intervention • Potential for progression of spinal disease causing neurological deficits Testing / Treatment / Diet Trial Priorities: - Next Tests: • Abdominal ultrasound for liver, kidney, GI tract, and foreign body detection • Urinalysis with sediment exam and protein quantification • Thoracic ultrasound or advanced imaging for pulmonary lesion characterization • Coagulation profile and inflammatory markers (e.g., CRP) • Repeat CBC and biochemistry to monitor trends - Diet Additions/Subtractions: • Remove high-fat, greasy, or damp-producing foods to reduce GI and hepatic burden • Consider renal-supportive diet if renal impairment confirmed • Supportive nutrition with easily digestible, warming foods per TCM guidance - Supplement Review Priorities: • Evaluate current supplements for hepatic or renal support (e.g., SAMe, milk thistle, omega-3 fatty acids) • Avoid nephrotoxic or hepatotoxic agents - Response-to-Treatment Markers: • Improvement in vomiting frequency and appetite • Stabilization or improvement in renal and hepatic parameters • Resolution or improvement of pulmonary opacity clinically and radiographically - RAC Follow-Up Priorities: • Monitor hydration status and clinical signs daily • Reassess imaging and labs in 5-7 days or sooner if deterioration occurs Next Snapshot Trigger: - New or worsening clinical signs such as increased vomiting, respiratory distress, neurological deficits, or changes in appetite/hydration - Results from abdominal ultrasound, urinalysis, or advanced thoracic imaging - Follow-up laboratory data showing progression or improvement of renal/hepatic parameters - Response or adverse reaction to initiated treatments or diet changes Clinical Caution: - This review is not a diagnosis. The veterinarian must interpret all evidence within the clinical context and consider the patient’s overall status. Further diagnostics and clinical correlation are essential before final conclusions or treatment plans are made.